Skip to main content
Signal8

CASTLEMAN PETER M

SEC insider (Form 3/4/5 filer). CIK 0001239594. Director at Caris Life Sciences, Inc. (CAI). 5 reported Form 4/5 transactions since Sep 2024; latest on Aug 14, 2026. Located in IRVING, TX.

Companies CASTLEMAN PETER M has filed insider reports for

  • Caris Life Sciences, Inc. (CAI): Director
CASTLEMAN PETER M profile photo

CASTLEMAN PETER M

CIK: 0001239594

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (20.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Caris Life Sciences, Inc. logo
CAI

Caris Life Sciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Caris Life Sciences, Inc. logo
    CAI

    Caris Life Sciences, Inc.

    Aug 14, 2026
    Award
    Direct
    13.2K shares-
  • Caris Life Sciences, Inc. logo
    CAI

    Caris Life Sciences, Inc.

    Feb 26, 2026
    Award
    Direct
    5.5K shares at avg. $20.06$111K
  • Caris Life Sciences, Inc. logo
    CAI

    Caris Life Sciences, Inc.

    Jan 9, 2026
    Exercise
    Direct
    2.5K shares at avg. $18.60$47K
  • Caris Life Sciences, Inc. logo
    CAI

    Caris Life Sciences, Inc.

    Jun 20, 2025
    Conversion
    Indirect
    10.2M shares-
  • Caris Life Sciences, Inc. logo
    CAI

    Caris Life Sciences, Inc.

    Feb 27, 2025
    Award
    Direct
    16.1K shares-

1-5 of 5